Back

Loss-of-function of ALDH3B2 transdifferentiates human pancreatic duct cells into beta-like cells

Li, J.; Bode, K.; Lee, Y.-c.; Morrow, N.; Ma, A.; Wei, S.; da Silva Pereira, J.; Stewart, T.; Lee-Papastavros, A.; Hollister-Lock, J.; Sullivan, B.; Bonner-Weir, S.; Yi, P.

2024-05-15 genetics
10.1101/2024.05.13.593941 bioRxiv
Show abstract

Replenishment of pancreatic beta cells is a key to the cure for diabetes. Beta cells regeneration is achieved predominantly by self-replication especially in rodents, but it was also shown that pancreatic duct cells can transdifferentiate into beta cells. How pancreatic duct cells undergo transdifferentiated and whether we could manipulate the transdifferentiation to replenish beta cell mass is not well understood. Using a genome-wide CRISPR screen, we discovered that loss-of-function of ALDH3B2 is sufficient to transdifferentiate human pancreatic duct cells into functional beta-like cells. The transdifferentiated cells have significant increase in beta cell marker genes expression, secrete insulin in response to glucose, and reduce blood glucose when transplanted into diabetic mice. Our study identifies a novel gene that could potentially be targeted in human pancreatic duct cells to replenish beta cell mass for diabetes therapy.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.